These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37164309)

  • 21. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America.
    Lima-Martínez MM; Colmenares L; Campanelli Y; Paoli M; Rodney M; Santos RD; Iacobellis G
    Clin Investig Arterioscler; 2019; 31(1):15-22. PubMed ID: 30166212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates.
    Brodovicz KG; Dekker JM; Rijkelijkhuizen JM; Rhodes T; Mari A; Alssema M; Nijpels G; Williams-Herman DE; Girman CJ
    Diabet Med; 2011 Sep; 28(9):1078-81. PubMed ID: 21843304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality.
    Silventoinen K; Pankow J; Lindström J; Jousilahti P; Hu G; Tuomilehto J
    Eur J Cardiovasc Prev Rehabil; 2005 Oct; 12(5):451-8. PubMed ID: 16210931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.
    Bernabe-Ortiz A; Perel P; Miranda JJ; Smeeth L
    Prim Care Diabetes; 2018 Dec; 12(6):517-525. PubMed ID: 30131300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristic of FINDRISC Score and Association with Diabetes Development in 6-Year Follow-Up in PURE Poland Cohort Study.
    Zatońska K; Basiak-Rasała A; Połtyn-Zaradna K; Różańska D; Karczewski M; Wołyniec M; Szuba A
    Vasc Health Risk Manag; 2021; 17():631-639. PubMed ID: 34611406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
    Soriguer F; Valdés S; Tapia MJ; Esteva I; Ruiz de Adana MS; Almaraz MC; Morcillo S; García Fuentes E; Rodríguez F; Rojo-Martinez G
    Med Clin (Barc); 2012 Apr; 138(9):371-6. PubMed ID: 21939990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM; Chia YC; Koay ZL
    Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort.
    Fizelova M; Jauhiainen R; Stančáková A; Kuusisto J; Laakso M
    PLoS One; 2016; 11(11):e0166584. PubMed ID: 27851812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between the Finnish Diabetes risk Score and the severity of coronary artery disease.
    Djurić P; Mladenović Z; Grdinić A; Tavčiovski D; Spasić M; Davičević-Elez Z
    Vojnosanit Pregl; 2014 May; 71(5):474-80. PubMed ID: 26137713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study.
    Mavrogianni C; Lambrinou CP; Androutsos O; Lindström J; Kivelä J; Cardon G; Huys N; Tsochev K; Iotova V; Chakarova N; Rurik I; Moreno LA; Liatis S; Makrilakis K; Manios Y;
    Diabetes Res Clin Pract; 2019 Apr; 150():99-110. PubMed ID: 30796939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
    BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occupational health care identifies risk for type 2 diabetes and cardiovascular disease.
    Viitasalo K; Lindström J; Hemiö K; Puttonen S; Koho A; Härmä M; Peltonen M
    Prim Care Diabetes; 2012 Jul; 6(2):95-102. PubMed ID: 22306176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of Seven Type 2 Diabetes Mellitus Risk Scores in a Population-Based Cohort: The CoLaus Study.
    Kraege V; Fabecic J; Marques-Vidal P; Waeber G; Méan M
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31781764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects.
    Lima-Martínez MM; Arrau C; Jerez S; Paoli M; González-Rivas JP; Nieto-Martínez R; Iacobellis G
    Prim Care Diabetes; 2017 Feb; 11(1):94-100. PubMed ID: 27914905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.
    Lindström J; Peltonen M; Eriksson JG; Aunola S; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2008 May; 31(5):857-62. PubMed ID: 18252900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.
    Costa B; Barrio F; Piñol JL; Cabré JJ; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O;
    BMC Med; 2013 Feb; 11():45. PubMed ID: 23438147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.
    Schwarz PE; Li J; Reimann M; Schutte AE; Bergmann A; Hanefeld M; Bornstein SR; Schulze J; Tuomilehto J; Lindström J
    J Clin Endocrinol Metab; 2009 Mar; 94(3):920-6. PubMed ID: 19106274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native Swedes.
    Bennet L; Groop L; Lindblad U; Agardh CD; Franks PW
    Prim Care Diabetes; 2014 Oct; 8(3):231-8. PubMed ID: 24472421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia): Baseline characteristics of the study participants.
    Acosta T; Barengo NC; Arrieta A; Ricaurte C; Tuomilehto JO
    Medicine (Baltimore); 2018 Jan; 97(1):e9285. PubMed ID: 29505512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translation, cross-cultural adaptation and validation of the Finnish Diabetes Risk Score (FINDRISC) for use in Brazilian Portuguese: questionnaire validity study.
    Conceição ALO; Corrêa NC; Ferreira PR; Rêgo AS; Silva FB; Carvalho STRF; Dias RDS; Paz BKB; Rocha VCC; Bassi-Dibai D
    Sao Paulo Med J; 2020 Jun; 138(3):244-252. PubMed ID: 32556059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.